Join oncology experts as they discuss their approaches to diagnosing and managing patients with gastrointestinal, genitourinary, lung, breast, gynecological, neuroendocrine and hematological cancers, sarcomas, and more. The conversations also explore cutting edge developments in precision oncology, as well as emerging treatments, including immunotherapy.
This independent medical education podcast is for HCPs with the ultimate goal of improving care for their patients. For more information, visit www.cor2ed.com
All content for COR2ED - Oncology Medical Conversation is the property of COR2ED Medical Education and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Join oncology experts as they discuss their approaches to diagnosing and managing patients with gastrointestinal, genitourinary, lung, breast, gynecological, neuroendocrine and hematological cancers, sarcomas, and more. The conversations also explore cutting edge developments in precision oncology, as well as emerging treatments, including immunotherapy.
This independent medical education podcast is for HCPs with the ultimate goal of improving care for their patients. For more information, visit www.cor2ed.com
The HER2 diagnostic and treatment landscape in NSCLC
COR2ED - Oncology Medical Conversation
18 minutes 36 seconds
6 months ago
The HER2 diagnostic and treatment landscape in NSCLC
Episode 2: Navigating common treatment scenarios in HER2-mutant NSCLC
This is the second episode of a two-part series on the HER2 diagnostic and treatment landscape in NSCLC, hosted by the Oncology Brothers, Drs Rohit and Rahul Gosain.
In this episode Drs Isabel Preeshagul and Eric Singhi provide the benefit of their experience when discussing how to approach different treatment scenarios in HER2-mutant NSCLC.
The conversation unfolds to cover;
How to distinguish HER2 alterations from other alterations on biomarker reports
The latest efficacy and safety data of currently approved and emerging treatments for HER2-altered NSCLC
The potential CNS activity of these treatments in patients with HER2-mutated NSCLC
How the treatment pathway may look in the near future
You can also watch a video of the experts in conversation and download the transcript on our website: https://cor2ed.com/lung-connect/programmes/her2-diagnostic-treatment-nsclc-2/
Or watch on YouTube: https://youtu.be/E8-3GDyJT9Y
Follow LUNG CONNECT on social media:
X – https://x.com/lung_connect
LinkedIn – https://www.linkedin.com/company/lungconnect/
This content is intended for healthcare professionals only.
The medical experts in this podcast are expressing their own views and not those of COR2ED, Supporters or their institution. This podcast is supported by an Independent Education Grant from Bayer.
This podcast is developed by cor2ed.com
Published on May 2025
Subscribe to this channel to stay up to date with new Independent Education programmes as they’re released.
COR2ED - Oncology Medical Conversation
Join oncology experts as they discuss their approaches to diagnosing and managing patients with gastrointestinal, genitourinary, lung, breast, gynecological, neuroendocrine and hematological cancers, sarcomas, and more. The conversations also explore cutting edge developments in precision oncology, as well as emerging treatments, including immunotherapy.
This independent medical education podcast is for HCPs with the ultimate goal of improving care for their patients. For more information, visit www.cor2ed.com
